SGLT2 Inhibitors: Real-World Data Show Benefits Outweigh Risks SGLT2 Inhibitors: Real-World Data Show Benefits Outweigh Risks

Use of an SGLT2 inhibitor was associated with more lower limb amputations and nonvertebral fractures in US patients with CKD and type 2 diabetes receiving routine care, but benefits still outweigh risks.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Nephrology News Source Type: news